This is particularly relevant given that survivin is considered a specific Tumor-Associated-Antigen (TAA) because the protein is overexpressed in most human cancers, but essentially absent in the respective normal tissues, although exceptions do exist [2, 89]. This evidence concerns the gene BIRC5 and cancer.